Jonathan Miller, general counsel at the U.S. Hemp Roundtable represented hemp stakeholders at a congressional hearing last week to determine if the U.S. Food and Drug Administration (FDA) had failed to meet its charter obligations by not moving to regulate CBD.

The FDA has